(Q43540894)

24 November 2017

Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system (English)

1 reference

24 November 2017

1 reference

1 reference

1 reference

1 reference

Gao X

1

1 reference

PubMed ID

11246153

24 November 2017

Dluzen DE

series ordinal

2

1 reference

PubMed ID

11246153

24 November 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

24 November 2017

1 reference

24 November 2017

103

1 reference

24 November 2017

2

1 reference

24 November 2017

385-394

1 reference

Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens.

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Methamphetamine causes lipid peroxidation and an increase in superoxide dismutase activity in the rat striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Methamphetamine-induced dopaminergic toxicity in mice. Role of environmental temperature and pharmacological agents

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Opposite modulatory effects of ovarian hormones on rat brain dopamine and serotonin transporters.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Sex differences in the rapid and acute effects of estrogen on striatal D2 dopamine receptor binding.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Estrous cycle-dependent variation in amphetamine-induced behaviors and striatal dopamine release assessed with microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Vitamin E and other antioxidants in neuroprotection.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Occurrence and distribution of dopamine in brain and other tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Sex steroids do not alter sex differences in tyrosine hydroxylase activity of dopaminergic neurons in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Effect of estradiol and tamoxifen on brain membranes: investigation by infrared and fluorescence spectroscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Inhibition of striatal dopamine transporter activity by 17beta-estradiol.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Estrogen as a neuromodulator of MPTP-induced neurotoxicity: effects upon striatal dopamine release.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Use of in vitro superfusion to assess the dynamics of striatal dopamine clearance: influence of estrogen.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

In vitro dopamine release from the rat striatum: diurnal rhythm and its modification by the estrous cycle.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic system

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Neuroprotective role of estrogen upon methamphetamine and related neurotoxins within the nigrostriatal dopaminergic system

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Tamoxifen eliminates estrogen's neuroprotective effect upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/B1 mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Comparisons between brain dopaminergic neurons of juvenile and aged rats: sex-related differences

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Nigrostriatal and mesolimbic dopaminergic activities were modified throughout the ovarian cycle of female rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Aged mice are more sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment than young adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Tamoxifen, raloxifene, and the prevention of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

[Sex hormones and antioxidant status]

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Estrogen treatment of dyskinetic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Methamphetamine-induced hyperthermia in mice: examination of dopamine depletion and heat-shock protein induction

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Gonadal hormones affect the hypothermia induced by serotonin1A (5-HT1A) receptor activation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Interactive effects of tamoxifen and estrogen upon the nigrostriatal dopaminergic system.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Tamoxifen alters dopamine output through direct actions upon superfused corpus striatal tissue fragments.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Interactive effects of tamoxifen and oestrogen upon the nigrostriatal dopaminergic system: long-term treatments.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Effects of estrogen treatment on sensorimotor task performance and brain dopamine concentrations in gonadectomized male and female CD-1 mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Sex differences and effects of estrogen on dopamine and DOPAC release from the striatum of male and female CD-1 mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Inhibition of synaptosomal high-affinity uptake of dopamine and serotonin by estrogen agonists and antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

The Impact of Gender and Estrogen on Striatal Dopaminergic Neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Antioxidant properties of steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Sex and estrous cycle variations of rat striatal dopamine uptake sites.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Methamphetamine-induced dopamine overflow and injury to striatal dopamine terminals: attenuation by dopamine D1 or D2 antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Acute stimulatory effect of estradiol on striatal dopamine synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Estrogens and dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Compensatory changes in striatal dopamine neurons following recovery from injury induced by 6-OHDA or methamphetamine: a review of evidence from microdialysis studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Neurochemical neutralization of methamphetamine with high-affinity nonselective inhibitors of biogenic amine transporters: a pharmacological strategy for treating stimulant abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Estrogens and the pathophysiology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

The effect of estrogen replacement on early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Estrogens and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Nitric oxide is a mediator of methamphetamine (METH)-induced neurotoxicity. In vitro evidence from primary cultures of mesencephalic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

The effect of pregnancy in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Attenuation of dopamine uptake in vivo following priming with estradiol benzoate.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Effects of estrogen on the basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Estrogens, Dopamine and Dyskinesias

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Sexual differences in sensitivity to methamphetamine toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Evaluation of the effects of inhibition of monoamine oxidase and senescence on methamphetamine-induced neuronal damage

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

The effect of oestradiol dipropionate and progesterone on monoamioe uptake in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Sexual differences and estrous cycle in methamphetamine-induced dopamine and serotonin depletions in the striatum of mice

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

Influence of gonadal hormones on sexual differences in sensitivity to methamphetamine-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900014-8

7 January 2021

10.1016/S0306-4522(01)00014-8

Identifiers

DOI

1 reference

24 November 2017

1 reference

PubMed ID

11246153